HANK & LIN'S GROUP
The past is prologue and the future is scintillating
2019
1. Huang Y, Liu S, Wu R, Zhang L, Zhang Y, Hong H, Zhang A, Xiao H, Liu Y, Wu Z, Zhu L, Kung HF. Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[18F]FEBGln. Bioorg Med Chem Lett. 2019 May 1;29(9):1047-1050.
2. Kung, Hank F., and Monte Blau. "Radioactive Se and Te Labeled Imaging Agents." Radiotracers for Medical Applications 1 (2019): 263-274.
3. Kung, Hank F., Seok Rye Choi, Wenchao Qu, Wei Zhang, and Daniel Skovronsky. "18F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer’s disease: a miniperspective." Journal of medicinal chemistry 53, no. 3 (2010): 933-941.
4. Kung, Hank F., Karen C. Rosenspire, and Robert H. Mach. "Monte Blau, PhD, 1926-2019 IN MEMORIAM." (2019): 11N-12N.
5. Kung, Hank F., and Monte Blau. "Radioactive Se and Te Labeled Imaging Agents." Radiotracers for Medical Applications 1 (2019): 263-274.
6. Shi, Shengyu, Lifeng Yao, Linlin Li, Zehui Wu, Zhihao Zha, Hank F. Kung, Lin Zhu, and De-Cai Fang. "Synthesis of novel technetium-99m tricarbonyl-HBED-CC complexes and structural prediction in solution by density functional theory calculation." Royal Society open science 6, no. 11 (2019): 191247.
7. Shi, Xinchong, Yan Zhang, Shaohua Xu, Hank F. Kung, Hongwen Qiao, LuLu Jiang, Lin Zhu et al. "Decreased striatal vesicular monoamine transporter type 2 correlates with the nonmotor symptoms in Parkinson disease." Clinical Nuclear Medicine 44, no. 9 (2019): 707-713.
8. Sun, Mingyue, Hao Xiao, Haiyan Hong, Aili Zhang, Yan Zhang, Yajing Liu, Lin Zhu, Hank F. Kung, and Jinping Qiao. "Rapid screening of nine unradiolabeled candidate compounds as PET brain imaging agents using cassette-wave microdosing and LC-MS/MS." Journal of Chromatography B1121 (2019): 28-38.
9. Yao, Xinyue, Zhihao Zha, Ruiyue Zhao, Seok Rye Choi, Karl Ploessl, Futao Liu, Lin Zhu, and Hank F. Kung. "Optimization of solid-phase extraction (SPE) in the preparation of [18F] D3FSP: A new PET imaging agent for mapping Aβ plaques." Nuclear Medicine and Biology 71 (2019): 54-64.
10. Zhang L, Yao X, Cao J, Hong H, Zhang A, Zhao R, Zhang Y, Zha Z, Liu Y, Qiao J, Zhu L, Kung HF. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia. Mol Pharm. 2019 Mar 4;16(3):1156-1166.
11. Zhang, Yan, Lifang Zhang, Jianhua Yang, Zehui Wu, Karl Ploessl, Zhihao Zha, Fei Liu et al. "Initial experience in synthesis of (2 S, 4 R)‐4‐[18F] fluoroglutamine for clinical application." Journal of Labelled Compounds and Radiopharmaceuticals 62, no. 5 (2019): 209-214.
12. Zhao, Ruiyue, Zhihao Zha, Xinyue Yao, Karl Ploessl, Seok Rye Choi, Futao Liu, Lin Zhu, and Hank F. Kung. "VMAT2 imaging agent, D6-[18F] FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization." Nuclear Medicine and Biology 72 (2019): 26-35.
13. Zhu, H., Liu, F., Zhang, Y. et al. (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application. Mol Imaging Biol 21, 945–953 (2019).
14. Green, Mark, Gary Hutchins, James Fletcher, Clint Bahler, Mark Tann, Justin Sims, Carla Mathias et al. "Initial evaluation of the PSMA-targeted PET agent [68Ga] Ga-P16-093, and comparison with [68Ga] Ga-PSMA-11, in prostate cancer patients presenting with biochemical recurrence." Journal of Nuclear Medicine May 2019, 60 (supplement 1)9.
15. Hong, Haiyan, Aili Zhang, Shengyu Shi, Zhihao Zha, Zehui Wu, Jinping Qiao, Karl Ploessl, Lin Zhu, and Hank Kung. "A simple kit-based preparation of [Ga-68] Ga-P15-041: A novel bone imaging agent." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S272-S273. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
16. Huang, Yong, Song Liu, Renbo Wu, Lifang Zhang, Yan Zhang, Haiyan Hong, Aili Zhang et al. "Synthesis and radiolabeling of a novel glutamine derivative:(2S, 4S) 4-[F-18] FEBGln." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S436-S438. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
17. Kung, Hank, Seok Rye Choi, Zzhihao Zha, Karl Ploessl, and David Alexoff. "[Ga-68]/[Lu-177] P17-087: A potential theranostic agent targeting PSMA expressing tumor." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S99-S100. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
18. Kung, Hank F. "Development of radiopharmaceutical; from bench to FDA approved clinical application." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S80-S80. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
19. Sun, Mingyue, Hao Xiao, Haiyan Hong, Aili Zhang, Yan Zhang, Yajing Liu, Lin Zhu, Hank Kung, and Jinping Qiao. "A novel high-throughput cassette microdosing approach to screen PET imaging agents." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S54-S56. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
20. Wong, Dean, Hiroto Kuwabara, Kelly Kitzmiller, Ayon Nandi, Zabecca Brinson, Noble George, David Alexoff et al. "Comparison of [18F] D3FSP ([18F] P16-129) and [18F] AV45 in Alzheimer’s Disease." Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1457
21. Xu, X., H. Zhu, L. Zhu, N. Li, H. Kung, and Z. Yang. "Comparison of F-18-(2S, 4R) 4-fluoroglutamine imaging between healthy and tumor subjects." In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 46, no. SUPPL 1, pp. S703-S704. ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES: SPRINGER, 2019.
22. Xu, Xiaoxia, Hua Zhu, Hank Kung, and Zhi Yang. "Dynamic PET/CT imaging of 18F-(2S, 4R) 4-fluoroglutamine in healthy volunteers and oncological patients." Journal of Nuclear Medicine May 2019, 60 (supplement 1) 206
23. X Xu, H Zhu, H Kung, Z Yang. “Solitary Brain and Neck Lesions Enhancing at MR Imaging: Evaluation with18F-(2S, 4R) 4-fluoroglutamine PET.” Journal of Nuclear Medicine May 2019, 60 (supplement 1)328
24.Xu, X., H. Zhu, L. Zhu, H. Kung, and Z. Yang. "Imaging benign and malignant intracranial tumors with F-18-fluoroglutamine PET." Journal of Nuclear Medicine May 2019, 60 (supplement 1)702.
25. Yao, Xinyue, Ruiyue Zhao, Zhihao Zha, Seok Choi, Karl Ploessl, David Alexoff, Lin Zhu, and Hank Kung. "Optimization of solid phase extraction (SPE) in preparation of D3-[18F] FSP: A new PET imaging agent for mapping Aβ plaques." Journal of Nuclear Medicine May 2019, 60 (supplement 1)485.
26. Zhang, Lifang, Yan Zhang, Futao Liu, Xinyue Yao, Zhihao Zha, Yajing Liu, Jinping Qiao, Lin Zhu, and Hank Kung. "An improved method for preparing [F-18] AV-45 using solid-phase extraction purification." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S173-S174. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
27. Zhang, Yan, Lifang Zhang, Zehui Wu, Jianhua Yang, Karl Ploessl, Zhihao Zha, Liu Fei et al. "Automated radiosynthesis of (2S, 4R)-4-[F-18] fluoroglutamine for clinical application." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 62, pp. S322-S323. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2019.
28. Zhao, Ruiyue, Zhihao Zha, Karl Ploessl, Seok Choi, Futao Liu, Lin Zhu, and Hank Kung. "Improved preparation of D6-[18F] FP-(+)-DTBZ: A new vesicular monoamine transporter 2 (VMAT2) imaging agent." Journal of Nuclear Medicine May 2019, 60 (supplement 1)1617.
29. Zhu, Hua, Xiaoxia Xu, Teli Liu, Xiaoyi Guo, Feng Wang, Nan Li, Lin Zhu, Hank Kung, and Zhi Yang. "Comparison between (2S, 4R) 4-[18F] fluoroglutamine and [18F]-FDG PET imaging of liver cancer from HepG-2 cell to patient." Journal of Nuclear Medicine May 2019, 60 (supplement 1)1409.
30. Zhu, H., Xu, X., Zhou, N., Zhang, Y., Liu, T., Guo, X., Yang, J., Wang, F., Li, N., Zhu, L. and Kung, H.F., 2019, May. Multi-mode molecular imaging of orthotopic HepG-2 liver hepatocellular carcinoma from animal to clinical:(2S, 4R) 4-[F-18] fluoroglutamine PET holds advantages. In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (Vol. 62, pp. S430-S430). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.
2018
1. Dunphy, Mark PS, et al. "In vivo PET assay of tumor glutamine flux and metabolism: in-human trial of 18F-(2 S, 4 R)-4-fluoroglutamine." Radiology 287.2 (2018): 667-675.
2. Liu, Fei, Xiaoxia Xu, Hua Zhu, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung, and Zhi Yang. "PET imaging of 18F-(2 S, 4 R) 4-fluoroglutamine accumulation in breast cancer: from xenografts to patients." Molecular Pharmaceutics 15, no. 8 (2018): 3448-3455.
3. Liu, Futao, Lin Zhu, Seok Rye Choi, Karl Plössl, Zhihao Zha, and Hank F. Kung. "Deuterium‐substituted 2‐(2′‐((dimethylamino) methyl)‐4′‐[18F](fluoropropoxy) phenylthio) benzenamine as a serotonin transporter imaging agent." Journal of Labelled Compounds and Radiopharmaceuticals 61, no. 8 (2018): 576-585.
4. Liu, Futao, Seok Rye Choi, Zhihao Zha, Karl Ploessl, Lin Zhu, and Hank F. Kung. "Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent." Nuclear Medicine and Biology 57 (2018): 42-49.
5. Xiao, Hao, Mingyue Sun, Ruiyue Zhao, Haiyan Hong, Aili Zhang, Shuxian Zhang, Futao Liu et al. "Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening." Journal of Pharmaceutical and Biomedical Analysis 154 (2018): 48-56.
6. Xu, Xiaoxia, Hua Zhu, Fei Liu, Yan Zhang, Jianhua Yang, Lifang Zhang, Lin Zhu, Nan Li, Hank F. Kung, and Zhi Yang. "Imaging brain metastasis patients with 18F-(2S, 4R)-4-fluoroglutamine." Clinical Nuclear Medicine 43, no. 11 (2018): e392-e399.
7. Zha, Zhihao, Karl Ploessl, Brian P. Lieberman, Limin Wang, and Hank F. Kung. "Alanine and glycine conjugates of (2S, 4R)-4-[18F] fluoroglutamine for tumor imaging." Nuclear Medicine and Biology 60 (2018): 19-28.
8. Zha, Zhihao, Karl Ploessl, Seok Rye Choi, Zehui Wu, Lin Zhu, and Hank F. Kung. "Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor." Nuclear medicine and biology 59 (2018): 36-47.
9. Zhang, Yan, Futao Liu, Hao Xiao, Xinyue Yao, Genxun Li, Seok Rye Choi, Karl Ploessl, Zhihao Zha, Lin Zhu, and Hank F. Kung. "Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain." Nuclear Medicine and Biology 66 (2018): 1-9.
10. Alexoff, David, Dohyun Kim, Hsiaoju Lee, Prashanth Padakanti, Alexander Schmitz, Anthony Page, Karl Ploessl, Zhihao Zha, Robert Mach, and Hank Kung. "A rapid prototyping platform for radiochemistry automation: experience with Ga-68 labeling." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1037;
11. Choi, Seok, Karl Ploessl, Zhihao Zha, Zehui Wu, David Alexoff, Lin Zhu, and Hank Kung. "A new 68Ga Glu-Urea-Lys (Ahx)-HBED-CC derivative as an imaging agent for PSMA." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 113.
12. Daube-Witherspoon, Margaret, David Alexoff, Hank Kung, Janet Reddin, Daniel Pryma, and Joel Karp. "Investigation of acquisition strategies for [68Ga] P15-041 bone imaging in prostate cancer." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1094.
13. Doot, Robert, David Alexoff, Daniel Pryma, Kyle Labban, Erin Schubert, Matthew Fillare, Karl Ploessl et al. "First in human experience with [68Ga] P16-093, a novel Ga-68 labeled Prostate Specific Membrane Antigen (PSMA) inhibitor." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 52.
14. Liu, Fei, Hua Zhu, Yan Zhang, Jianhua Yang, Lifang Zhang, Xiaoxia Xu, Xiaoyi Guo, Lin Zhu, Hank Kung, and Zhi Yang. "Synthesis and Correlation Evaluation of 18F-(2S, 4R) 4-fluoroglutamine in c-Myc expression in Breast Cancer." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1292
15. Ploessl, Karl, Seok Choi, David Alexoff, Futao Liu, Lin Zhu, and Hank Kung. "Deuterium substituted D6FPDTBZ (P17-059) as a new VMAT2 imaging agent." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1030.
16. Xu, Xiaoxia, Hua Zhu, Fei Liu, Nan Li, Lin Zhu, Hank Kung, and Zhi Yang. "Preliminary clinical trasnationl study of 18F-(2S, 4R) 4-fluoroglutamine PET/CT imaging in 17 breast cancer patients." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1277.
17. Xu, Xiaoxia, Hua Zhu, Fei Liu, Nan Li, Lin Zhu, Hank Kung, and Zhi Yang. "Metabolism analysis and PET imaging of 18F-(2S, 4R) 4-fluoroglutamine and its application in Brain Metastases." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 57.
18. Zha, Zhihao, Karl Ploessl, David Alexoff, Seok Choi, Zehui Wu, Lin Zhu, and Hank Kung. "[18F] D3FSP ([18F] D3AV-45) as a PET imaging agent for Abeta plaques in the brain." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1031.
19. Zhu, Hua, Fei Liu, Xiaoxia Xu, Teli Liu, Nan Li, Lin Zhu, Hank Kung, and Zhi Yang. "18F-(2S, 4R) 4-Fluoroglutamine as a promise PET imaging tracer for myelosuppression detection." Journal of Nuclear Medicine May 2018, 59 (supplement 1) 121.
2017
1. Cao, Jianhua, Yajing Liu, Lifang Zhang, Fenghua Du, Yingqian Ci, Yan Zhang, Hao Xiao et al. "Synthesis of novel PEG-modified nitroimidazole derivatives via “hot-click” reaction and their biological evaluation as potential PET imaging agent for tumors." Journal of Radioanalytical and Nuclear Chemistry 312, no. 2 (2017): 263-276.
2. Choi, Seok Rye, Karl Ploessl, Lin Zhu, and Hank F. Kung. "PET Imaging Agents for Alzheimer’s Disease." In Alzheimer’s Disease II, pp. 181-197. Springer, Cham, 2017.
3. Zhou, Rong, Austin R. Pantel, Shihong Li, Brian P. Lieberman, Karl Ploessl, Hoon Choi, Eric Blankemeyer et al. "[18F](2S, 4R) 4-fluoroglutamine PET detects glutamine pool size changes in triple-negative breast cancer in response to glutaminase inhibition." Cancer research 77, no. 6 (2017): 1476-1484.
4. Zhu, Lin, Karl Ploessl, Rong Zhou, David Mankoff, and Hank F. Kung. "Metabolic imaging of glutamine in cancer." Journal of Nuclear Medicine 58, no. 4 (2017): 533-537. DOI: 10.2967/jnumed.116.182345
5. Alexoff, David, Robert Doot, Daniel Pryma, Erin Schubert, Zehui Wu, Zhihao Zha, Seok Choi et al. "Preliminary kinetic analysis of [68Ga] P15-041, a novel 68Ga labeled bisphosphonate, from first-in-human studies." Journal of Nuclear Medicine May 2017, 58 (supplement 1)388.
6. Cao, Jianhua, Yajing Liu, Lifang Zhang, Lin Zhu, Hank F. Kung, and Jinping Qiao. "Radiolabelling and evaluation of novel nitroimidazole derivatives as potential PET imaging agents for tumors." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 60, pp. S418-S418. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2017.
7. Xiao, Hao, Shuxian Zhang, Yan Zhang, Jianhua Cao, Lifang Zhang, Hank F. Kung, Lin Zhu, and Jinping Qiao. "Study the brain penetration of diaryl sulfides as SERT imaging agents by LC-MS/MS." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 60, pp. S323-S323. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2017.
8. Zhang, Lifang, Jianhua Cao, Xinyue Yao, Yan Zhang, Jinping Qiao, Yajing Liu, Zhihao Zha, Lin Zhu, and Hank F. Kung. "Novel F-18 labeled nitroimidazole derivatives containing a 2-fluoropropionyl ester group for imaging hypoxia." In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 60, pp. S349-S349. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2017.
2016
1. Jeitner, Thomas M., Eva Kristoferson, Juan A. Azcona, John T. Pinto, Clint Stalnecker, Jon W. Erickson, Hank F. Kung, Jianyong Li, Karl Ploessl, and Arthur JL Cooper. "Fluorination at the 4 position alters the substrate behavior of l-glutamine and l-glutamate: Implications for positron emission tomography of neoplasias." Journal of fluorine chemistry 192 (2016): 58-67.
2. Qiao, Hongwen, Yan Zhang, Zehui Wu, Lin Zhu, Seok Rye Choi, Karl Ploessl, and Hank F. Kung. "One-step preparation of [18F] FPBM for PET imaging of serotonin transporter (SERT) in the brain." Nuclear Medicine and Biology 43, no. 8 (2016): 470-477.
3. Song, Jin, Zehui Wu, Beau Wangtrakuldee, Seok Rye Choi, Zhihao Zha, Karl Ploessl, Robert H. Mach, and Hank Kung. "4-(((4-Iodophenyl) methyl)-4 H-1, 2, 4-triazol-4-ylamino)-benzonitrile: A Potential Imaging Agent for Aromatase." Journal of Medicinal Chemistry 59, no. 20 (2016): 9370-9380.
4. Wu, Zehui, Zhihao Zha, Seok Rye Choi, Karl Plössl, Lin Zhu, and Hank F. Kung. "New 68Ga-PhenA bisphosphonates as potential bone imaging agents." Nuclear Medicine and Biology 43, no. 6 (2016): 360-371.
5. Zha, Zhihao, Jin Song, Seok Rye Choi, Zehui Wu, Karl Ploessl, Megan Smith, and Hank Kung. "68Ga-bivalent polypegylated styrylpyridine conjugates for imaging Aβ plaques in cerebral amyloid angiopathy." Bioconjugate Chemistry 27, no. 5 (2016): 1314-1323.
6. Kung, Hank, Seok Choi, Karl Ploessl, Zhihao Zha, and Zehui Wu. "New 68Ga Glu-Urea-Lys (Ahx)-HBED-CC-bisphosponate as a dual-targeted imaging agent for PSMA and bone metastasis." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1395.
7. Kung, Hank. "New 68ga hbed-bisphosponates and their derivatives as bone imaging agents." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1106.
8. Song, Jin, Zehui Wu, Seok Choi, Karl Ploessl, and Hank Kung. "A potential imaging agent for aromatase: 4-[[(4-iodophenyl) methyl]-4H-1, 2, 4-triazol-4-ylamino]-benzonitrile." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1334.
9. Wu, Zehui, Zhihao Zha, Seok Choi, Karl Ploessl, Lin Zhu, and Hank Kung. "New 68Ga AAZTA-bisphosphonates as potential bone imaging agents." Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1380
10. Zha, Zhihao, Seok Choi, Lin Zhu, Jin Song, Zehui Wu, Karl Ploessl, and Hank Kung. "Multidentate 68Ga-Polypegylated Styrylpyridines for imaging of β-Amyloid deposition in cerebral angiopathy (CAA)." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1808.
11. Zha, Zhihao, Zehui Wu, Seok Choi, Karl Ploessl, Lin Zhu, and Hank Kung. "New 68Ga Glu-Urea-Lys (Ahx)-HBED-CC Derivatives as Prostate Specific Membrane Antigen (PSMA) Imaging Agents." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1366.
12. Zhou, Rong, Brian Lieberman, Shihong Li, Karl Ploessl, Hoon Choi, Eric Blankemeyer, Sharon Lee et al. "[18F](2S, 4R) 4-Fluoroglutamine PET Detects Changes in Glutamine Pool in Triple Negative Breast Cancer in Response to Glutaminase Inhibition." Journal of Nuclear Medicine May 2016, 57 (supplement 2)1363.
2015
1. Dunphy, Mark, James J. Harding, Jason Stuart Lewis, Ingo K. Mellinghoff, Antonio Marcilio Padula Omuro, James Hsieh, Hanwen Zhang et al. "Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status." Journal of Clinical Oncology 33, no. 15_suppl (May 20, 2015) 11014.
2. Ploessl, Karl, Brian P. Lieberman, Seok Rye Choi, Lin Zhu, and Hank F. Kung. "L-[5-11 C]-Glutamine and Metabolic Imaging in Cancer Cells." In Glutamine in Clinical Nutrition, pp. 113-124. Humana Press, New York, NY, 2015.
3. Venneti, Sriram, Mark P. Dunphy, Hanwen Zhang, Kenneth L. Pitter, Patrick Zanzonico, Carl Campos, Sean D. Carlin et al. "Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo." Science translational medicine 7, no. 274 (2015): 274ra17-274ra17.
4. Wu, Xianying, Xue Zhou, Shuxian Zhang, Yan Zhang, Aifang Deng, Jie Han, Lin Zhu, Hank F. Kung, and Jinping Qiao. "Brain uptake of a non-radioactive pseudo-carrier and its effect on the biodistribution of [18 F] AV-133 in mouse brain." Nuclear Medicine and Biology 42, no. 7 (2015): 630-636.
